History of prostate, bladder, or rectal cancer 
History of transurethral resection of the prostate (TURP), open prostate surgery, or radiofrequency or microwave therapies 
History of open bladder, rectosigmoid colon, or other pelvic surgery 
Patient is unwilling to discontinue alpha blockers 1 month after study treatment 
Patient is unwilling to discontinue 5-alph reductase inhibitors 1 month after study treatment 
Neurogenic bladder or other neurologic disorder impacting bladder function such as Parkinson's disease, multiple sclerosis, cerebral vascular accident or diabetes 
Any other confounding bladder or urethral pathology, including urethral stricture, bladder neck contracture, or bladder atonia 
Active prostatitis or urinary tract infection 
Cystolithiasis within the past 3 months 
Serum creatinine > 1.7mg/dL 
Inability to discontinue oral anticoagulant 2-5 days prior to study treatment 
Coagulation disturbances not normalized by medical treatment 
Iodinated contrast allergy that, in the opinion of the Investigator, cannot be adequately premedicated 
Gelatin allergy 
Known severe peripheral vascular disease or major iliac arterial occlusive disease 
Interest in future fertility 
Clinically significant cardiac arrhythmia or other cardiac disease (including congestive heart failure), uncontrolled diabetes mellitus, clinically significant respiratory disease, or known immunosuppression 
Other condition that the Investigator believes puts the patient at risk for a complication during the procedure       
    
